WASHINGTON, DC (STL.News) The Securities and Exchange Commission has filed an Administrative Proceeding (File No. 3-20350) against Immune Pharmaceuticals, Inc., Order Instituting Administrative Proceedings and Notice of Hearing and Notice of Hearing pursuant to Section 12 (j) of the Securities Exchange Act of 1934.